Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

NCT03947411 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Influenza

Interventions

DRUG: Oseltamivir Phosphate
DRUG: Xiyanping injection+Oseltamivir Phosphate

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]